BEAC (carmustine, etoposide, cytarabine, and cyclophosphamide) in autologous hematopoietic cell transplantation: a safe and effective alternative conditioning regimen for Hodgkin and non-Hodgkin lymphoma.

Subjects

Subjects :

Antineoplastic Combined Chemotherapy Protocols pharmacology
Carmustine pharmacology
Cyclophosphamide pharmacology
Cytarabine pharmacology
Etoposide pharmacology
Female
Humans
Lymphoma, Non-Hodgkin mortality
Male
Retrospective Studies
Survival Analysis
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Carmustine therapeutic use
Cyclophosphamide therapeutic use
Cytarabine therapeutic use
Etoposide therapeutic use
Hematopoietic Stem Cell Transplantation methods
Hodgkin Disease drug therapy
Lymphoma, Non-Hodgkin drug therapy
Transplantation Conditioning methods
Transplantation, Autologous methods

Details

Language :

English

ISSN :

1476-5365

Volume :

54

Issue :

6

Database :

MEDLINE

Journal :

Bone marrow transplantation

Publication Type :

Editorial & Opinion

Accession number :

30410083

Full Text :

https://doi.org/10.1038/s41409-018-0395-y